Where Does Vistagen Therapeutics Inc (VTGN) Stock Fall in the Biotechnology Field After It Has Fallen 0.00% This Week?

Vistagen Therapeutics Inc (VTGN) is near the bottom in its industry group according to InvestorsObserver. VTGN gets an overall rating of 38. That means it scores higher than 38 percent of stocks. Vistagen Therapeutics Inc gets a 31 rank in the Biotechnology industry. Biotechnology is number 38 out of 148 industries.

VTGN has an Overall Score of 38. Find out what this means to you and get the rest of the rankings on VTGN!

See Full VTGN Report

What do These Ratings Mean?

Analyzing stocks can be hard. There are tons of numbers and ratios, and it can be hard to remember what they all mean and what counts as “good” for a given value. InvestorsObserver ranks stocks on eight different metrics. We percentile rank most of our scores to make it easy for investors to understand. A score of 38 means the stock is more attractive than 38 percent of stocks. These scores are not only easy to understand, but it is easy to compare stocks to each other. You can find the best stock in an industry, or look for the sector that has the highest average score. The overall score is a combination of technical and fundamental factors that serves as a good starting point when analyzing a stock. Traders and investors with different goals may have different goals and will want to consider other factors than just the headline number before making any investment decisions.

What's Happening With Vistagen Therapeutics Inc Stock Today?

Vistagen Therapeutics Inc (VTGN) stock is unmoved -3.57% while the S&P 500 has fallen -0.6% as of 10:50 AM on Friday, Mar 24. VTGN is unchanged $0.00 from the previous closing price of $0.14 on volume of 1,461,198 shares. Over the past year the S&P 500 has fallen -13.16% while VTGN has fallen -88.80%. VTGN lost -$0.31 per share the over the last 12 months. Click Here to get the full Stock Report for Vistagen Therapeutics Inc stock.